Assessment of the interval between diagnosis and definitive treatment of lung cancer at a public institution in São Paulo

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Retrospective observational study examines treatment delays in lung cancer patients, highlighting risks.

An average waiting period of 425.6 days for lung cancer treatment was observed, raising concerns about patient health.
During this waiting period, 70% of lung cancer patients progressed to a higher stage, which may impact treatment outcomes.
This observational study utilized medical records to track the timeline from diagnosis to surgical treatment for lung cancer.
Minimizing the interval between diagnosis and treatment is crucial to enhance lung cancer patient outcomes.

Fiuza et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark